Cancer patient advocates from 26 European countries, active across a wide spectrum of cancer types, spent four days last week at the first training course to be developed and run by advocates themselves.The intensive training ‘Academy’ was organised by WECAN [more]
Coordinating Chair – Fatima Cardoso Chairs – Eric P. Winer, Larry Norton, Alberto Costa Co-Chairs – Giuseppe Curigliano, Shirley A. Mertz The International Consensus Conference for Advanced Breast Cancer (ABC) will take place in Lisbon, Portugal, [more]
Despite growing precision in understanding the biology of breast cancer, progress in extending survival of people with metastatic disease remains frustratingly slow. Median survival is only about three years, having edged up only slightly in [more]
Scientist or artist? Michael Peckham, who is best known for his contribution to the treatment of testicular cancer and Hodgkin lymphoma, and was involved in founding the European School of Oncology, refuses to choose and [more]
Cancer patients are put at risk unless the surgeons who operate on them understand the principles of the disease, work closely with other oncology disciplines, and know which patients need to be referred to high-volume [more]
In many books used for teaching the alphabet to children, the letter A is associated to an apple: the association may seem obvious, but usually it is not so for an African child: in Africa [more]
The European School of Oncology has lost a supporter, colleague and friend, writes Mike Clarke, who co-chaired ESO’s Systematic Reviews Masterclass alongside Patrick Johnston. With the sudden and unexpected death of Patrick Johnston on 4 [more]
An ESO task force met to discuss the potential for “biosimilar” medical products in oncology, analyzing facts and debunking some myths. Some of the most used biologic drugs in oncology are going off patent in [more]
ESO’s brochure “Who’s Who and Programmes 2017” is now available (click on the image to download the pdf).
The first edition of the Joint “ESO-DFCI Breast Cancer in Young Women Symposium” will be held during the Breast Cancer: New Horizons, Current Controversies Course, on July 15 in Boston, United States. Breast cancer in [more]
The programme is designed for postgraduate medical doctors at any stage of clinical career who are interested in haematological oncology. A mix of experienced clinicians or pathologists etc., and oncology/haematology trainees is welcome. Scientists [more]
Delaying treatment for a curable prostate cancer is an increasingly popular option among men with low risk tumours. Simon Crompton looks at efforts to learn more about who benefits and how to avoid delaying too [more]
Any educational effort in the rare cancer area makes little sense if disconnected from a networking environment.Thus, this Course will be first offered to clinical oncologists involved into the existing networks covering rare adult solid [more]